Clinical Trials Review for Alcoholic Hepatitis Market

1
Alcoholic Hepatitis Global Clinical Trials
Review, H2, 2015
2
Report Description
Summary The clinical trial report, Alcoholic
Hepatitis Global Clinical Trials Review, H2, 2015
provides an overview of Alcoholic Hepatitis
clinical trials scenario. This report provides
top line data relating to the clinical trials on
Alcoholic Hepatitis. Report includes an overview
of trial numbers and their average enrollment in
top countries conducted across the globe. The
report offers coverage of disease clinical trials
by region, country (G7 E7), phase, trial
status, end points status and sponsor type.
Report also provides prominent drugs for
in-progress trials (based on number of ongoing
trials). The Clinical Trial Reports are generated
usingproprietary database - Pharma eTrack
Clinical trials database. Clinical trials are
collated from 80 different clinical trial
registries, conferences, journals, news etc
across the globe. Clinical trials database
undergoes periodic update by dynamic
process. The report enhances the decision making
capabilities and helps to create an effective
counter strategies to gain competitive
advantage. Get complete Report _at_
http//www.bigmarketresearch.com/alcoholic-hepati
tis-global-clinical-trials-review-h2-2015-market
3
Report Description

• Scope
• - The report provides a snapshot of the global
  clinical trials landscape
• - Report provides top level data related to the
  clinical trials by Region, Country (G7 E7),
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• - The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• - The report provides all the unaccomplished
  trials (Terminated, Suspended and Withdrawn) with
  reason for unaccomplishment
• - The Report provides enrollment trends for the
  past five years
• -Report provides latest news for the past three
  months
• Enquire About this report _at_ http//www.bigmarketre
  search.com/report-enquiry/381412

4
Report Description
Reasons to buy - Assists in formulating key
business strategies with regards to investment -
Helps in identifying prominent locations for
conducting clinical trials which saves time and
cost - Provides top level analysis of Global
Clinical Trials Market which helps in identifying
key business opportunities - Supports
understanding of trials count and enrollment
trends by country in global therapeutics market -
Aids in interpreting the success rates of
clinical trials by providing a comparative
scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials -
Facilitates clinical trial assessment of the
indication on a global, regional and country
level
5
Table of Contents
Table Of Contents Table of Contents List of
Tables List of Figures Report Guidance Clinical
Trials by Region Clinical Trials and Average
Enrollment by Country Top Countries Contributing
to Clinical Trials in Asia-Pacific Top Five
Countries Contributing to Clinical Trials in
Europe Top Countries Contributing to Clinical
Trials in North America Top Countries
Contributing to Clinical Trials in Middle East
and Africa Clinical Trials by G7 Countries
Proportion of Alcoholic Hepatitis to
Gastrointestinal Clinical Trials Clinical Trials
by Phase in G7 Countries Clinical Trials in G7
Countries by Trial Status Clinical Trials by E7
Countries Proportion of Alcoholic Hepatitis to
Gastrointestinal Clinical Trials Clinical Trials
by Phase in E7 Countries Clinical Trials in E7
Countries by Trial Status Clinical Trials by
Phase In Progress Trials by Phase
6
Table of Contents
Clinical Trials by Trial Status Clinical Trials
by End Point Status Subjects Recruited Over a
Period of Time Clinical Trials by Sponsor Type
Prominent Sponsors Top Companies Participating
in Alcoholic Hepatitis Therapeutics Clinical
Trials Prominent Drugs Latest Clinical Trials
News on Alcoholic Hepatitis Nov 23, 2015
Generon Collaborating with Mayo Clinic to
Initiate a Phase IIa Study with F-652, a
First-in-Class Biologic, to Treat Patients with
Alcoholic Hepatitis Sep 28, 2015 Vital
Therapies Outlines Plans for New Phase 3 Trial of
ELAD in Alcohol-Induced Liver Decompensation
Clinical Trial Profile Snapshots Appendix
Abbreviations Definitions Research Methodology
Secondary Research Contact Us Disclaimer
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/alcoholic-hepatit
is-global-clinical-trials-review-h2-2015-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States